National Disease Research Interchange

Medical research organization based in Philadelphia, PA. 49 employees. Exempt under §501(c)(3).

MissionTHE MISSION OF NDRI IS TO PROVIDE HUMAN BIOSPECIMENS WORLDWIDE TO ADVANCE BIOMEDICAL/BIOSCIENCE RESEARCH AND DEVELOPMENT AND EDUCATION IN THE LIFE SCIENCES.

EIN
23-2213205
State
PA
Sector
Medical research
Budget band
$10M–$25M
Latest filing
TY 2024
Records
7 officers · 6 years

Financial snapshot · TY 2024

$11.3M
Total revenue
$10.6M
Total expenses
$7.1M
Net assets

Financial health · TY 2024

48
Moderate financial health
Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.
Reserve ratio
16
2.8 months of expenses
Program efficiency
57
72.9% spent on programs
Revenue diversity
97
Mix of program fees, grants & contributions

Leadership compensation

William Leinweber
PRESIDENT & CEO
$501,709
66th percentile vs. peers
Thomas Bell
CHIEF SCIENTIFIC OFFICER
$261,112
66th percentile vs. peers
Thomas Malecki
CFO; VP, ADMINISTRATION
$220,783
39th percentile vs. peers
Melissa W Vondran
SR VP, OPERATIONS & DIRECTOR BIOREPOSITORY
$197,950
66th percentile vs. peers
Dana R Rosales
DIRECTOR, FULFILLMENT
$155,420
66th percentile vs. peers

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.

Claim this page
National Disease Research Interchange Executive Compensation | 990 Data | DoubleNine